logo

For the Inventor, By the Inventor

Seoul, South Korea

Yong Joo Jun

This inventor holds 9 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Cnpharm Co. Ltd., Board of Trustees, Ewha Womans University, Ewha University-Industry Collaboration Foundation. Active years: 1995-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Joo Jun. Retrieved from https://idiyas.com/inventor/yong-joo-jun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal6 out of 10 
 
Cnpharm Co. Ltd.
 patents
silverMedal1 out of 3 
 
Board of Trustees, Ewha Womans University
 patents
bronzeMedal1 out of 204 
 
Ewha University-Industry Collaboration Foundation
 patents
4. 1 out of 1,063 
 
Goldstar, Co., Ltd.
 patents

Years Active: 1995-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 11912829 - Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same (2024-02-27),
2. 11180615 - Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same (2021-11-23),
3. 10590243 - Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same (2020-03-17),
4. 10584214 - Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same (2020-03-10),
5. 10336867 - Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same (2019-07-02),
6. 8344173 - Dendritic oligopeptide-grafteded cyclotriphosphazene, a process for the preparation thereof and a drug delivery system containing the same (2013-01-01),
7. 7598318 - Thermosensitive and biocompatible amphiphilic poly(organophosphazenes) and preparation method thereof (2009-10-06),
8. 6951953 - Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof (2005-10-04),
9. 5442410 - Video cassette recorder having variable, high-resolution video screen (1995-08-15),

Title: Yong Joo Jun: Innovator in Polyphosphazene Compounds

Introduction

Yong Joo Jun is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of polymer chemistry, particularly in the development of cationic polyphosphazene compounds. With a total of 9 patents to his name, his work focuses on innovative drug delivery systems that exhibit enhanced selectivity and reduced toxicity.

Latest Patents

Among his latest patents are the cationic polyphosphazene compound and the polyphosphazenes-drug conjugate compound. These inventions relate to a new class of cationic linear polyphosphazenes that incorporate hydrophilic poly(ethylene glycol) as side groups. The compounds also feature spacer groups selected from various amino alcohols and oligopeptides containing lysine. The polyphosphazene-drug conjugates are designed to covalently bond with hydrophobic anticancer drugs, showcasing outstanding tumor selectivity and low toxicity.

Career Highlights

Yong Joo Jun has worked with notable organizations, including Cnpharm Co. Ltd. and the Ewha University-Industry Collaboration Foundation. His career reflects a commitment to advancing the field of drug delivery through innovative polymer chemistry.

Collaborations

He has collaborated with esteemed colleagues such as Youn Soo Sohn and Prakash Gouda Avaji, contributing to the advancement of research in his field.

Conclusion

Yong Joo Jun's innovative work in polyphosphazene compounds positions him as a key figure in the development of effective drug delivery systems. His contributions continue to impact the field of polymer chemistry and cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…